Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomatitis 3Head and Neck Neoplasms 2Mucositis 1Head and Neck Cancer Patients Treated With Radiotherapy 1

Interventions

Low-Level Light Therapy 14Fibroblast Growth Factor 7 10Cisplatin 6Standard of Care 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Propolis 4Mouthwashes 4Cryotherapy 4Water 3Sodium Bicarbonate 3Saline Solution 3Radiotherapy 3Laser Therapy 3Injections 3Drug Therapy 3Control Groups 3Benzydamine 3golotimod 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Vitamin E 2Vitamin B 12 2Sodium Chloride 2Saliva, Artificial 2RRx-001 2Practice Guidelines as Topic 2Lidocaine 2Honey 2Glutamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Stomatitis × Benzydamine × Clear all
NCT05055726 2022-11-16

BOOM

Aziende Chimiche Riunite Angelini Francesco S.p.A

Phase 4 Completed
100 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT05323058 2022-05-11

The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy

Cairo University

Phase 2 Unknown
42 enrolled

Stomatitis

NCT00051441 2011-05-19

Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3 Completed
605 enrolled

Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡